Quick Answer
Cell Source, Inc. reported Stockholders Equity of -$15.61 million for fiscal year 2023.
Cell Source, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2023 | -$15.61M | -23.6% |
| 2022 | -$12.63M | -28.6% |
| 2021 | -$9.83M | -23.6% |
| 2020 | -$7.95M | -38.4% |
| 2019 | -$5.74M | -16.7% |
| 2018 | -$4.92M | -8.0% |
| 2017 | -$4.56M | +27.0% |
| 2016 | -$6.24M | -8.4% |
| 2015 | -$5.76M | -52.2% |
| 2014 | -$3.78M | -442.6% |
| 2013 | -$697.3K | -373.2% |
| 2012 | -$147.4K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | -$18.94M | -18.2% | -9.4% |
| June 30, 2024 | -$17.32M | -15.9% | -3.4% |
| March 31, 2024 | -$16.75M | -17.8% | -7.3% |
| December 31, 2023 | -$15.61M | -23.6% | +2.6% |
| September 30, 2023 | -$16.03M | -34.1% | -7.3% |
| June 30, 2023 | -$14.95M | -38.8% | -5.1% |
| March 31, 2023 | -$14.22M | -42.2% | -12.6% |
| December 31, 2022 | -$12.63M | -28.6% | -5.7% |
- Cell Source, Inc. showed a decrease of -23.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2023 period, Cell Source, Inc.’s stockholders equity has declined by 10494.1% (from -$147.4 thousand to -$15.61 million).
- The most recent figure is from Cell Source, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on June 24, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: